Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
70,841,842
-
Share change
-
+1,214,035
-
Total reported value
-
$2,095,507,190
-
Put/Call ratio
-
179%
-
Price per share
-
$29.58
-
Number of holders
-
264
-
Value change
-
+$47,113,352
-
Number of buys
-
147
-
Number of sells
-
116
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2023
As of 31 Dec 2023 TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) had 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 70,841,842 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, EMINENCE CAPITAL, LP, FMR LLC, ArrowMark Colorado Holdings LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, Bellevue Group AG, and Champlain Investment Partners, LLC.
This table shows 264 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.